The individualed dose titration guided by the insulin like growth hormone one response of the patient offers similar efficacy and a lower incidence of side effects than the traditional, step-wise, weight based dosing schedule.
SPECIFIC AIM : The individualized dosing approach was adopted by the GH Research Society Consensus but differs from present Humatrope prescribing information. This study will document dosing efficacy and the """"""""non-inferiority"""""""" of this approach.
Showing the most recent 10 out of 515 publications